For over 75 years, Beckman Coulter has been a global leader in providing scalable solutions to optimise lab efficiency and reduce costs
Danaher is helping to improve patient care by enabling health systems to push the limits in their field and address the complex analytical challenges they face. Committed to improving healthcare, Danaher offers a breadth of leading-edge companies in clinical diagnostics.
Danaher’s diagnostics businesses offer a broad range of analytical instruments, reagents, consumables, software and services used to diagnose disease and make treatment decisions in hospital labs and other critical care settings. Among those businesses is Beckman Coulter Diagnostics.
Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimise the clinical laboratory. The company’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results – particularly important in today’s integrated health delivery system. For more than 75 years, Beckman Coulter has been a global leader devoted to providing scalable solutions to laboratories of all sizes – offering a broad portfolio of chemistry, immunoassay, haematology, urinalysis, automation and information systems.
As it becomes increasingly pertinent to position their services within the larger healthcare landscape, laboratories are tasked with streamlining every workflow process to eliminate waste, minimise variation and reduce costs. For years, Beckman Coulter has worked with its customers to simplify very complex laboratory processes – standardising processes and results.
Well-executed standardisation programmes greatly improve the quality of laboratory measurements and also ensure that laboratories across the healthcare system are producing credible and comparable data. They are therefore able to reduce inefficiency, error, duplication and delays that contribute to unnecessary expenditures.
Automation and workflow innovation
Integrated health delivery systems benefit from Beckman Coulter’s continuous investment in technologies that automate, consolidate and accelerate the delivery of results. The company’s products and lean expertise remove unnecessary steps in laboratory processes – saving time and helping the health systems achieve the lowest total cost of ownership.
As a leader in workflow innovation, partnership with Beckman Coulter helps laboratories deliver value-based care across the entire integrated health delivery system. This enables
the lab to achieve critical outcomes such as reduced inefficiencies, errors and delays – all of which contribute to unnecessary expenditures.
Diagnostic testing in the laboratory plays a crucial role in the detection, diagnosis and treatment of disease in patients. Laboratory tests help determine the presence, extent or absence of disease and monitor the effectiveness of treatment. An estimated 60–70 percent of all decisions regarding a patient’s diagnosis and treatment, hospital admission and discharge are based on laboratory test results. However, decision makers sometimes overlook the contribution an efficient laboratory service can have on the entire health delivery system.
Partnering for profit
In today’s changing landscape, the clinical laboratory can increase its profitability without needing to become a cost centre. With the right configurable solutions and technologies, laboratories can become extremely efficient – and so reduce process waste, which in turn results in actual
Today, laboratories are exploring ways to find partnerships. By leveraging the opportunity and bridging the gap in the services they can provide, many healthcare systems are working toward test consolidation and standardisation within the expanding hub and spoke networks. Once operationally efficient, these laboratory services have been shown to provide high visibility within the hospital, as a function that brings in extra value. Additionally, many healthcare systems are seeking to provide services that increase their efficiency, while still maintaining the required quality of results.
Science with a purpose
Health delivery systems can benefit from Beckman Coulter’s legacy of innovation around highly prevalent disease states, such as cardiac, cancer, anaemia and reproductive health. By focusing on science with a purpose, Beckman Coulter monitors the ever-changing guidelines for disease management and responds with novel, standardised solutions that ensure credible and consistent results are generated across laboratories in the entire health care network.
With a legacy of innovation stemming from its founders, Arnold O. Beckman and Wallace and Joseph Coulter, who invented the very first pH meter and the Coulter Principle, respectively, Beckman Coulter Diagnostics makes science and innovation in the laboratory its business.